A Study of the Clinical Patterns of Hair Loss in Female Patients

    April 2024 in “ Clinical dermatology review (Print) ”
    Sweta R. Prabhu, Madhavi Madhusudhana, Soumya Bhute … S. B. Athanikar
    Studysummary In this descriptive hospital-based study, researchers found that telogen effluvium was the most common cause of hair loss among women aged 20 to 40, with most cases occurring over 6 weeks to 6 months without an associated illness.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 10

    1. Telogen Effluvium Associated with COVID-19 Infection Dermatologic Therapy · 2021
    2. What Can Hair Tell Us About COVID-19? Experimental Dermatology · 2020
    3. Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience Dermatologic Therapy · 2020
    4. Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019 Open Forum Infectious Diseases · 2020
    5. Correlation Between Clinical Features, Biochemical Parameters, and Histopathological Findings in Women with Patterned Baldness: A Study from North India PubMed · 2019
    6. Diffuse Hair Loss in Females Indian Dermatology Online Journal · 2019
    7. Prevalence of Nutritional Deficiencies in Hair Loss Among Indian Participants: Results of a Cross-Sectional Study International Journal of Trichology · 2017
    8. Female Pattern Hair Loss: Causes, Diagnosis, and Treatment Options Indian Journal of Dermatology, Venereology and Leprology · 2013
    9. Diffuse Hair Loss in an Adult Female: Approach to Diagnosis and Management Indian Journal of Dermatology, Venereology and Leprology · 2009
    10. Hair Loss in Women The New England Journal of Medicine · 2007